Spots Global Cancer Trial Database for hormone receptor negative malignant tumor breast triple
Every month we try and update this database with for hormone receptor negative malignant tumor breast triple cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Phase I/II Single-arm Trial of Azenosertib (ZN-c3) Combined With Carboplatin and Pembrolizumab in Patients With Metastatic Triple-negative Breast Cancer (ZAP-IT) | NCT06351332 | Breast Cancer Breast Cancer F... Triple Negative... Hormone Recepto... HER2-negative B... | Azenosertib Carboplatin Pembrolizumab | 18 Years - | Dana-Farber Cancer Institute |